The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ability of routine blood tests (RBTs) in asymptomatic patients (pts) with indolent non-Hodgkin lymphoma (iNHL) to detect relapse or clinically significant disease progression.
 
Oliver Piercey
No Relationships to Disclose
 
Zoe Loh
No Relationships to Disclose
 
Joanna Chan
No Relationships to Disclose
 
Geoffrey Chong
Research Funding - BeiGene; Bristol-Myers Squibb; Hutchison MediPharma; Incyte; Merck Serono; Novartis; Pharmacyclics
 
Andrew Grigg
Honoraria - Gilead Sciences; MSD Oncology
Consulting or Advisory Role - Gilead Sciences; Janssen-Cilag; MSD Oncology; Roche; Takeda
Expert Testimony - MSD
Travel, Accommodations, Expenses - Roche
 
Steven Cheema
No Relationships to Disclose
 
Tania Cushion
Honoraria - Janssen
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Janssen; MSD
 
Gurjot Gill
No Relationships to Disclose
 
Matthew Whybird
Stock and Other Ownership Interests - BH Biotech
Patents, Royalties, Other Intellectual Property - BH Biotech
 
Eliza Anne Hawkes
Consulting or Advisory Role - Celgene; Janssen-Cilag; Merck Sharpe & Dohme (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag; Roche/Genentech; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Merck KGaA (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Roche/Genentech